EUVIMEDОткрийте EUVIMED
Open access · CC BY 4.0

Tumor microenvironment‐responsive delivery nanosystems reverse immunosuppression for enhanced CO gas/immunotherapy

Beibei Chen, Kangli Guo, Xiaoyi Zhao, Zhiwen Liu, Chen Xu, Nana Zhao iD, Fu-Jian Xu

Exploration · 2023-12 · 3 (6)

DOI: 10.1002/exp.20220140 ↗

At a glance

Journal article in Exploration, published online on 2023-07-27. Written by Beibei Chen and 6 co-authors. Institution: State Key Laboratory of Chemical Resource Engineering Beijing University of Chemical Technology Beijing China. Cited 98 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

Carbon monoxide (CO) gas therapy demonstrates great potential to induce cancer cell apoptosis and antitumor immune responses, which exhibits tremendous potential in cancer treatment. However, the therapeutic efficacy of CO therapy is inhibited by the immunosuppressive tumor microenvironment (TME). Herein, a facile strategy is proposed to construct hollow‐structured rough nanoplatforms to boost antitumor immunity and simultaneously reverse immunosuppression by exploring intrinsic immunomodulatory properties and morphological optimization of nanomaterials. The TME‐responsive delivery nanosystems (M‐RMH) are developed by encapsulating the CO prodrug within hollow rough MnO 2 nanoparticles and the subsequent surface functionalization with hyaluronic acid (HA). Rough surfaces are designed to facilitate the intrinsic properties of HA‐functionalized MnO 2 nanoparticles (RMH) to induce dendritic cell maturation and M1 macrophage polarization by STING pathway activation and hypoxia alleviation through enhanced cellular uptake. After TME‐responsive degradation of RMH, controlled release of CO is triggered at the tumor site for CO therapy to activate antitumor immunity. More importantly, RMH could modulate immunosuppressive TME by hypoxia alleviation. After the combination with aPD‐L1‐mediated checkpoint blockade therapy, robust antitumor immune responses are found to inhibit both primary and distant tumors. This work provides a facile strategy to construct superior delivery nanosystems for enhanced CO/immunotherapy through efficient activation of antitumor immune responses and reversal of immunosuppression.

Subjects

Author keywords

CO therapyhypoxia alleviationrough surfacetumor microenvironment

Authors and institutions

  • State Key Laboratory of Chemical Resource Engineering Beijing University of Chemical Technology Beijing China.
  • Key Laboratory of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology), Beijing Laboratory of Biomedical Materials Beijing University of Chemical Technology Beijing China.
  • College of Materials Sciences and Engineering Beijing University of Chemical Technology Beijing China.

ORCID profiles: Nana Zhao

Funding

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Cite

APA

Chen, B., Guo, K., Zhao, X., Liu, Z., Xu, C., Zhao, N., & Xu, F. J. (2023). Tumor microenvironment‐responsive delivery nanosystems reverse immunosuppression for enhanced CO gas/immunotherapy. Exploration, 3(6). https://doi.org/10.1002/exp.20220140

Vancouver

Chen B, Guo K, Zhao X, Liu Z, Xu C, Zhao N, et al. Tumor microenvironment‐responsive delivery nanosystems reverse immunosuppression for enhanced CO gas/immunotherapy. Exploration. 2023;3(6). doi:10.1002/exp.20220140

BibTeX
@article{Chen2023,
  author = {Chen, Beibei and Guo, Kangli and Zhao, Xiaoyi and Liu, Zhiwen and Xu, Chen and Zhao, Nana and Xu, Fu-Jian},
  title = {Tumor microenvironment‐responsive delivery nanosystems reverse immunosuppression for enhanced CO gas/immunotherapy},
  journal = {Exploration},
  year = {2023},
  volume = {3},
  number = {6},
  doi = {10.1002/exp.20220140}
}
Start for free →